Related Experiment Videos
Clinical Pharmacology of Carvedilol
Insights
Carvedilol, a beta-blocker, improves heart failure outcomes by offering multiple pharmacological actions. It reduces hospitalizations and mortality while enhancing left ventricular function.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Beta-blockers are established treatments for heart failure.
- Carvedilol possesses unique pharmacological properties contributing to its efficacy in heart failure.
Purpose of the Study:
- To review the clinical pharmacology of carvedilol.
- To emphasize its clinical effects in heart failure management.
Main Methods:
- Review of existing clinical pharmacology data.
- Emphasis on carvedilol's effects in heart failure patients.
Main Results:
- Carvedilol is approved for hypertension, angina, and heart failure.
- It exhibits nonselective beta-blockade, alpha-1 blockade, antioxidant, and anti-proliferative effects.
Conclusions:
- Carvedilol acts as a multi-action neurohormonal antagonist.
- Benefits include reduced hospitalization/mortality and improved cardiac function in heart failure.
Abstract:
BACKGROUND: There is now a wealth of data supporting the use of beta-blockers in heart failure and the additional pharmacological properties of carvedilol are thought to play an important role in the therapeutic efficacy of carvedilol in this disease. METHODS AND RESULTS: Carvedilol is licensed for the treatment of essential hypertension, chronic stable angina, and mild to moderate chronic heart failure. This article provides an up-to-date review of the clinical pharmacology of carvedilol, with particular emphasis on its clinical effects in heart failure. CONCLUSION: Carvedilol is a multiple-action neurohormonal antagonist that offers nonselective beta-blockade, alpha-1 blockade, antioxidant, anti-ischemic mortality, and anti-proliferative properties. In addition to reductions in hospitalization and mortality rates, benefits of carvedilol in heart failure include dramatic improvements in left ventricular function and other parameters of cardiac remodeling.